Development of a Non-Invasive Method, Multiplex Methylation Specific PCR (MMSP), for Early Diagnosis of Nasopharyngeal Carcinoma

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Zhang, Zhe ^a,b   Sun, Di ^a,b   Hutajulu, Susanna Hilda ^c   Nawaz, Imran ^a   Nguyen Van, Do ^a,e   Huang, Guangwu ^b   Haryana, Sofia M ^c   Middeldorp, Jaap M ^d   Ernberg, Ingemar ^a   Hu, Li Fu ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^c GADJAH MADA UNIVERSITY   (Indonesia)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e HANOI MEDICAL UNIVERSITY   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; EPSTEIN BARR VIRUS ANTIGEN 1; GENOMIC DNA; LATENT MEMBRANE PROTEIN 1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; VIRUS DNA;

ARTICLE; BIOPSY; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH ASSOCIATED PROTEIN KINASE GENE; DNA METHYLATION; EARLY DIAGNOSIS; EBNA1 GENE; EPSTEIN BARR VIRUS INFECTION; GENE; HUMAN; HUMAN CELL; LATENT MEMBRANE PROTEIN 1 GENE; MULTIPLEX METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; MULTIPLEX POLYMERASE CHAIN REACTION; NASOPHARYNGEAL BIOPSY; NASOPHARYNGEAL SWAB; NASOPHARYNX CARCINOMA; NON INVASIVE MEASUREMENT; NOSE SMEAR; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1 ISOFORM A GENE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; THROAT CULTURE; TUMOR CELL;

CELL LINE; DNA; DNA METHYLATION; EPSTEIN-BARR VIRUS INFECTIONS; GENES, TUMOR SUPPRESSOR; HERPESVIRUS 4, HUMAN; HUMANS; NASOPHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION;

HUMAN HERPESVIRUS 4;

EID: 84868380146     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045908     Document Type: Article

References (29)

1. Chi KH, Chang YC, Guo WY, Leung MJ, Shiau CY, et al. (2002) A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys 52: 1238-1244.
2. Wei WI, Kwong DL, (2010) Current management strategy of nasopharyngeal carcinoma. Clin Exp Otorhinolaryngol 3: 1-12.
3. Agulnik M, Siu LL, (2005) State-of-the-art management of nasopharyngeal carcinoma: current and future directions. Br J Cancer 92: 799-806.
4. Zeng Y, (1985) Seroepidemiological studies on nasopharyngeal carcinoma in China. Adv Cancer Res 44: 121-138.
5. Sham JS, Wei WI, Zong YS, Choy D, Guo YQ, et al. (1990) Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy. Lancet 335: 371-374.
6. Tsang RK, Vlantis AC, Ho RW, Tam JS, To KF, et al. (2004) Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review. Head Neck 26: 598-602.
7. Stevens SJ, Verkuijlen SA, Hariwiyanto B, Harijadi, Fachiroh J, et al. (2005) Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia. J Clin Microbiol 43: 3066-3073.
8. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, et al. (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60: 5954-5958.
9. Schulz W, (2005) Qualified promise: DNA methylation assays for the detection and classification of human cancers. J Biomed Biotechnol 2005: 227-229.
10. Rush LJ, Plass C, (2002) Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications. Anal Biochem 307: 191-201.
11. Kantlehner M, Kirchner R, Hartmann P, Ellwart JW, Alunni-Fabbroni M, et al. (2011) A high-throughput DNA methylation analysis of a single cell. Nucleic Acids Res 39: e44.
12. Gitan RS, Shi H, Chen CM, Yan PS, Huang TH, (2002) Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res 12: 158-164.
13. Ahluwalia A, Yan P, Hurteau JA, Bigsby RM, Jung SH, et al. (2001) DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization. Gynecol Oncol 82: 261-268.
14. Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, et al. (1988) Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42: 329-338.
15. Hu LF, Minarovits J, Cao SL, Contreras-Salazar B, Rymo L, et al. (1991) Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5′-flanking region. J Virol 65: 1558-1567.
16. Wong TS, Chang HW, Tang KC, Wei WI, Kwong DL, et al. (2002) High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients. Clin Cancer Res 8: 433-437.
17. Kwong J, Lo KW, To KF, Teo PM, Johnson PJ, et al. (2002) Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 8: 131-137.
18. Hutajulu SH, Indrasari SR, Indrawati LP, Harijadi A, Duin S, et al. (2011) Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population. Mol Cancer. May 2 10: 48.
19. Teo CG, Griffin BE, (1987) Epstein-Barr virus genomes in lymphoid cells: activation in mitosis and chromosomal location. Proc Natl Acad Sci U S A 84: 8473-8477.
20. Gullo C, Low WK, Teoh G, (2008) Association of Epstein-Barr virus with nasopharyngeal carcinoma and current status of development of cancer-derived cell lines. Ann Acad Med Singapore 37: 769-777.
21. Busson P, Ganem G, Flores P, Mugneret F, Clausse B, et al. (1988) Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer 42: 599-606.
22. Olek A, Oswald J, Walter J, (1996) A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res 24: 5064-5066.
23. Stevens SJ, Verkuijlen SA, Hariwiyanto B, Harijadi, Paramita DK, et al. (2006) Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Int J Cancer. Aug 1 119 (3) (): 608-14.
24. Chang HW, Chan A, Kwong DL, Wei WI, Sham JS, et al. (2003) Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient. Int J Cancer 105: 851-855.
25. Esteller M, Corn PG, Baylin SB, Herman JG, (2001) A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229.
26. Fernandez AF, Rosales C, Lopez-Nieva P, Grana O, Ballestar E, et al. (2009) The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 19: 438-451.
27. Lo KW, Kwong J, Hui AB, Chan SY, To KF, et al. (2001) High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 61: 3877-3881.
28. Kim DH, Nelson HH, Wiencke JK, Christiani DC, Wain JC, et al. (2001) Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer. Oncogene 20: 1765-1770.
29. Stebbing J, Bower M, Syed N, Smith P, Yu V, et al. (2006) Epigenetics: an emerging technology in the diagnosis and treatment of cancer. Pharmacogenomics 7: 747-757.